SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-405879
Filing Date
2014-11-10
Accepted
2014-11-10 15:50:56
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d802347d10q.htm 10-Q 790987
2 EX-31.1 d802347dex311.htm EX-31.1 9431
3 EX-31.2 d802347dex312.htm EX-31.2 9452
4 EX-32.1 d802347dex321.htm EX-32.1 4244
5 EX-32.2 d802347dex322.htm EX-32.2 4265
  Complete submission text file 0001193125-14-405879.txt   4943860

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT aegr-20140930.xml EX-101.INS 686356
7 XBRL TAXONOMY EXTENSION SCHEMA aegr-20140930.xsd EX-101.SCH 39270
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aegr-20140930_cal.xml EX-101.CAL 63683
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aegr-20140930_def.xml EX-101.DEF 125800
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aegr-20140930_lab.xml EX-101.LAB 346306
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aegr-20140930_pre.xml EX-101.PRE 246556
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 141208498
SIC: 2834 Pharmaceutical Preparations